Syngene International, a subsidiary of Indian biotechnology major, BIOCON Ltd, and Bristol-Myers Squibb Company (NYSE:BMY) announced today the opening of a fully dedicated research and development ...

Syngene International has received a follow-up from the U.S. FDA related to an inspection earlier this year at one of its manufacturing sites near Bengaluru. The company shared the update in a stock ...

Add Yahoo as a preferred source to see more of our stories on Google. MUMBAI (Reuters) - Biotechnology firm Biocon Ltd(BION.NS) could file a prospectus for a share listing for its research services ...

Rumors have it that Biocon plans to sell some of its research-services business, Syngene International, and file for an initial public offering for Syngene within the next two months. At the same time ...

PRINCETON, N.J. & BANGALORE, India--Bristol-Myers Squibb (NYSE:BMY) and Syngene International, India's largest contract research organization, today announced a five-year extension of their drug ...

MUMBAI (Reuters) - Biocon Ltd will list its research services business arm Syngene by selling up to 15 percent stake in a public offer, the company said, after reporting third-quarter earnings. Biocon ...

MUMBAI (Reuters) - Drugmaker Biocon Ltd may hive off its contract research services arm, Syngene International Ltd, in the long run to help fund the development of its own products, it said, ahead of ...

MUMBAI (Reuters) - Biotechnology firm Biocon Ltd could file a prospectus for a share listing for its research services business arm Syngene International within the next two months, two sources ...